Baird Medical Investment Holdings (BDMD) Common Equity (2023 - 2026)

Baird Medical Investment Holdings (BDMD) has reported Common Equity for 4 consecutive years, with $34.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 2.8% year-over-year to $34.6 million in Q2 2026; TTM through Jun 2026 was $34.6 million, a 2.8% decrease from a year earlier, with the FY2025 full-year figure at $31.2 million, down 21.47% from the prior year.
• Common Equity was $34.6 million for Q2 2026 at Baird Medical Investment Holdings, up from $31.2 million in the prior quarter.
• Over five years, Common Equity peaked at $39.8 million in Q4 2024 and troughed at $31.2 million in Q4 2025.
• A 4-year average of $35.4 million and a median of $35.6 million in 2025 frame the typical range for Common Equity.
• Across the five-year window, Common Equity grew 11.35% in 2024 and retreated 21.47% in 2025, its largest moves.
• Over 4 years, Common Equity stood at $35.7 million in 2023, then increased by 11.35% to $39.8 million in 2024, then decreased by 21.47% to $31.2 million in 2025, then gained by 10.9% to $34.6 million in 2026.
• The last three Common Equity figures came in at $34.6 million (Q2 2026), $31.2 million (Q4 2025), and $35.6 million (Q2 2025), per Business Quant data.